Antagonists of BMP and TGFBeta signalling pathways

Details for Australian Patent Application No. 2005225080 (hide)

Owner The Research Foundation of the State University of New York HSC Research and Development Limited Partnership

Inventors Wrana, Jeffrey; Thomsen, Gerald H

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005225080

Parent 782355

Filing date 20 October 2005

Wipo publication date 8 December 2005

Acceptance publication date 2 July 2009

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

17 November 2005 Complete Application Filed

8 December 2005 Application Open to Public Inspection

  Published as AU-B-2005225080

2 July 2009 Application Accepted

  Published as AU-B-2005225080

7 January 2010 Standard Patent Sealed

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005225081-Use of dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants

2005225079-Electromagnetic trip device and electrical protection apparatus